New drug shows promise for blood cancer in small japanese study
NCT ID NCT05673460
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 27 times
Summary
This early-phase study tested a drug called nemtabrutinib in 7 Japanese adults with certain blood cancers (like leukemia or lymphoma) that had not responded to prior treatments. The main goals were to check safety, side effects, and how the drug moves through the body. Researchers also looked for early signs that the drug might help control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MATURE B-CELL NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chiba Cancer Center ( Site 0005)
Chiba, 260-8717, Japan
-
Kindai University Hospital ( Site 0006)
Sayama, Osaka, 589-8511, Japan
-
Kyushu University Hospital ( Site 0008)
Fukuoka, 812-8582, Japan
-
Nagoya University Hospital ( Site 0003)
Nagoya, Aichi-ken, 466-8560, Japan
-
National Cancer Center Hospital East ( Site 0002)
Kashiwa, Chiba, 2778577, Japan
-
Okayama University Hospital ( Site 0007)
Okayama, 700-8558, Japan
-
Yamagata University Hospital ( Site 0001)
Yamagata, 990-9585, Japan
Conditions
Explore the condition pages connected to this study.